Skip to main content

Advertisement

Table 1 Patient inclusion and exclusion criteria

From: Japan useful medication program for schizophrenia (JUMPs)-long-term study on discontinuation rate, resolution and remission, and improvement in social functioning rate associated with atypical antipsychotic medications in patients with schizophrenia

Criteria
Patients satisfying all of the following requirements are eligible.
Outpatients aged 20 years or over at the time of consent acquisition
Patients with schizophrenia satisfying the DSM-IV-TR diagnostic criteria
Patients requiring antipsychotic treatment or switching from the current antipsychotic medication to others because of lack of efficacy, intolerability, or other reasons
Patients capable of issuing consent to participate in the study in writing
Exclusion criteria
Patients falling under any of the following criteria are excluded from this study.
Patients having a history of allergy to any component of the test drugs or risperidone
Patients under strong influence from drugs that suppress the central nervous system, such as barbiturate derivatives
Patients receiving adrenaline
Patients receiving azole antifungal agents (excluding topical preparations) or HIV protease inhibitors
Patients with moderately or severely compromised renal function (creatinine clearance less than 50 mL/min at the time of eligibility assessment)
Patients with poorly controlled diabetes mellitus (HbA1c (NGSP) over 8.4% at the time of eligibility assessment)
Patients presenting with severe symptoms despite sufficient antipsychotic treatment or patients having a history of clozapine therapy
Patients having other psychiatric disease in addition to schizophrenia
Patients with complication of Parkinson’s disease
Patients presenting with malignant syndrome or similar symptoms or patients with water poisoning
Patients having signs of physical exhaustion, such as dehydration and malnutrition
Patients having malignant tumor requiring treatment
Patients with a history of alcohol or drug abuse
Pregnant or possibly pregnant women, lactating women, or women desiring to become pregnant during the study period
Patients likely to attempt suicide (CGI-SS class 4 or higher (severe tendency for suicide))
Other patients judged by the physician in charge as inappropriate for the study
  1. DSM-IV-TR, Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision; HIV, human immunodeficiency virus; HbA1c, glycohemoglobin A1c; NGSP, National Glycohemoglobin Standardization Program; CGI-SS, Clinical Global Impression-Suicide Scale.